Chao-Wen Cheng

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2014-2024
Publications (10 Years): 13

Top Topics

Tyrosine Kinase

Long Noncoding Rna

Top Venues

European journal of clinical investigation

Disease markers

Journal of clinical medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Chih-Chieh Chang, Yoko K Takada, Chao-Wen Cheng, Yukina Maekawa, Seiji Mori, Yoshikazu Takada
FGF9, a Potent Mitogen, Is a New Ligand for Integrin αvβ3, and the FGF9 Mutant Defective in Integrin Binding Acts as an Antagonist. Cells 13 (4) (2024)
Chih-Chieh Chang, Yoko K Takada, Chao-Wen Cheng, Yukina Maekawa, Seiji Mori, Yoshikazu Takada
FGF9, a Potent Mitogen, Is a New Ligand for Integrin αvβ3, and the FGF9 Mutant Defective in Integrin Binding Acts as an Antagonist. Cells 13 (4) (2024)
Chih-Chieh Chang, Yoko K Takada, Chao-Wen Cheng, Yukina Maekawa, Seiji Mori, Yoshikazu Takada
FGF9, a Potent Mitogen, Is a New Ligand for Integrin αvβ3, and the FGF9 Mutant Defective in Integrin Binding Acts as an Antagonist. Cells 13 (4) (2024)
Chih-Chieh Chang, Yoko K Takada, Chao-Wen Cheng, Yukina Maekawa, Seiji Mori, Yoshikazu Takada
FGF9, a Potent Mitogen, Is a New Ligand for Integrin αvβ3, and the FGF9 Mutant Defective in Integrin Binding Acts as an Antagonist. Cells 13 (4) (2024)
Chih-Chieh Chang, Yoko K Takada, Chao-Wen Cheng, Yukina Maekawa, Seiji Mori, Yoshikazu Takada
FGF9, a Potent Mitogen, Is a New Ligand for Integrin αvβ3, and the FGF9 Mutant Defective in Integrin Binding Acts as an Antagonist. Cells 13 (4) (2024)
Yu-Ching Chang, Chung-Ze Wu, Chao-Wen Cheng, Jin-Shuen Chen, Li-Chien Chang
Redrawing Urokinase Receptor (uPAR) Signaling with Cancer Driver Genes for Exploring Possible Anti-Cancer Targets and Drugs. Pharmaceuticals (Basel, Switzerland) 16 (10) (2023)
Wei-Cheng Chang, Cho-Hao Lee, Shih-Hwa Chiou, Chen-Chung Liao, Chao-Wen Cheng
Aqueous Lumican Correlates with Central Retinal Thickness in Patients with Idiopathic Epiretinal Membrane: A Proteome Study. Disease markers 2022 (2022)
Wei-Cheng Chang, Cho-Hao Lee, Shih-Hwa Chiou, Chen-Chung Liao, Chao-Wen Cheng
Proteomic Analysis of Aqueous Humor Proteins in Association with Cataract Risks: Diabetes and Smoking. Journal of clinical medicine 10 (24) (2021)
Chao-Wen Cheng, Chiao-Wen Lin, Yuan-Hung Wang, Wen-Fang Fang, Ying-Chin Lin, Kam-Tsun Tang, Jiunn-Diann Lin
Associations of secreted phosphoprotein 1 and B lymphocyte kinase gene polymorphisms with autoimmune thyroid disease. European journal of clinical investigation 49 (3) (2019)
Chao-Wen Cheng, Kam-Tsun Tang, Wen-Fang Fang, Jiunn-Diann Lin
Synchronized expressions of serum osteopontin and B cell-activating factor in autoimmune thyroid disease. European journal of clinical investigation 49 (7) (2019)
Jiunn-Diann Lin, Shun-Fa Yang, Yuan-Hung Wang, Wen-Fang Fang, Kam-Tsun Tang, Chao-Wen Cheng
Associations of gene polymorphisms in interferon-alpha signature-related genes with autoimmune thyroid diseases. Clinical endocrinology 91 (6) (2019)
En-Yuan Lin, Amarzaya Chagnaadorj, Shyh-Jer Huang, Ching-Chiung Wang, Yung-Hsiao Chiang, Chao-Wen Cheng
Hepatoprotective Activity of the Ethanolic Extract of Polygonum multiflorum Thunb. against Oxidative Stress-Induced Liver Injury. Evidence-based complementary and alternative medicine : eCAM 2018 (2018)
Chao-Wen Cheng, Che-Chang Chang, Hsiu-Wen Chen, Ching-Yu Lin, Jin-Shuen Chen
Serum ApoA4 levels predicted the progression of renal impairment in T2DM. European journal of clinical investigation 48 (6) (2018)
Jin-Shuen Chen, Li-Chien Chang, Shyh-Jer Huang, Chao-Wen Cheng
Targeting spleen tyrosine kinase-Bruton's tyrosine kinase axis for immunologically mediated glomerulonephritis. BioMed research international 2014 (2014)
Tao-Wei Ke, Han-Lin Hsu, Yu-Hua Wu, William Tzu-Liang Chen, Ya-Wen Cheng, Chao-Wen Cheng
MicroRNA-224 suppresses colorectal cancer cell migration by targeting Cdc42. Disease markers 2014 (2014)